Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0394-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Synergistic Inhibition of Head and Neck Tumor Growth by Green Tea (−)‐epigallocatechin‐3‐gallate and EGFR Tyrosine Kinase Inhibitor

International Journal of Cancer
Cancer ResearchOncology
2008English

PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2015English

HDAC Inhibitor SAHA Induces McPip1 Expression and Suppresses IL-6 Expression in Human OA Chondrocytes

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Development of Bowman-Birk Inhibitor for Chemoprevention of Oral Head and Neck Cancer

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2001English

Correction: Synergistic Interaction Between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer CellsIn VitroandIn Vivo

Clinical Cancer Research
Cancer ResearchOncology
2018English

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

SATB2 Augments ΔNp63α in Head and Neck Squamous Cell Carcinoma

EMBO Reports
BiochemistryGeneticsMolecular Biology
2010English

A Different Approach to the EGFR Inhibitor Gefitinib Involving Solid-Phase Synthesis

Synlett
Organic Chemistry
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy